Former FDA Commissioner: Precision med has evolved badly

The latest stories trending on MedCity News.

Editor's Pick

Top Story "Precision Med Has Evolved as Badly As I Expected" And Other Takeaways From Former FDA Commissioner At PMWC Robert Califf addressed a range of issues, including AI, lack of nutrition resources at the FDA and how he evaluates the progress of precision medicine at the Precision Medicine World Conference in Silicon Valley. Join us May 20 & 21, 2025 in Chicago for INVEST 2025! Benefits of Attending INVEST 2025 Networking Opportunities: Connect with diverse healthcare professionals to forge valuable partnerships. Expert Insights: Gain insights from top speakers on cutting-edge healthcare advancements. Knowledge Sharing: Participate in interactive sessions and Q&A sessions. And Much More! Register Now & Save $345

Featured News

Oral Metabolic Drug Acquired by Novo Nordisk Continues to Show Concerning Neuro Side Effects Novo Nordisk's monlunabant showed signs of neuropsychiatric side effects in a mid-stage diabetic kidney disease study, despite a drug design intended to favor hitting its target receptor in peripheral tissues rather than the brain. Neuro effects were also reported last year in a Phase 2 test of this pill in obesity. Little Otter Raises $9.5M for Family Mental Health Little Otter's $9.5 million fundraise included participation from Pivotal Ventures, Torch Capital, Springbank, CRV, Next Legacy, G9, Gratitude Railroad and Carrie Walton Penner's Fiore Ventures. The company has raised more than $36 million to date. Navigating Complex Regulatory Landscapes in the Biopharmaceutical Industry It is imperative to understand the various regulatory variations globally, develop a strategy for new technologies, engage in harmonization activities, and implement risk management measures. Balancing Innovation and Risk in Healthtech While new technologies may demonstrate clinical benefits in controlled settings, their true value is determined by how well they fit into existing healthcare workflows.

Resources

MedCity FemFwd: Comparing Maternal Health in Employer-Sponsored Populations vs. Medicaid Presented by MedCity News In this episode, we're joined by Emily Lindemer, an executive director at Morgan Health. Lindemer discusses a recent report she co-authored, which focuses on maternal health opportunities in employer-sponsored insurance. Listen now

MedCity News • PO Box 901 • New York, NY unsubscribe